Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Harvard Business School
Argus Health
Teva
McKesson
Julphar
Queensland Health
Federal Trade Commission
Covington

Generated: October 22, 2018

DrugPatentWatch Database Preview

J And J Company Profile

« Back to Dashboard

What is the competitive landscape for J AND J, and what generic alternatives to J AND J drugs are available?

J AND J has thirty-two approved drugs.

There are eight US patents protecting J AND J drugs.

Summary for J And J
US Patents:8
Tradenames:25
Ingredients:12
NDAs:32

Drugs and US Patents for J And J

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc TYLENOL acetaminophen TABLET, EXTENDED RELEASE;ORAL 019872-001 Jun 8, 1994 OTC Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
J And J Consumer Inc PEPCID COMPLETE calcium carbonate; famotidine; magnesium hydroxide TABLET, CHEWABLE;ORAL 020958-001 Oct 16, 2000 OTC Yes Yes 5,989,588*PED ➤ Try a Free Trial ➤ Try a Free Trial
J And J Consumer Inc TYLENOL acetaminophen SUPPOSITORY;RECTAL 017756-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
J And J Consumer Inc SINE-AID IB ibuprofen; pseudoephedrine hydrochloride TABLET;ORAL 019899-001 Dec 31, 1992 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial
J And J Consumer Inc ZYRTEC ALLERGY cetirizine hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 022578-001 Sep 3, 2010 OTC Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
J And J Consumer Inc MOTRIN MIGRAINE PAIN ibuprofen TABLET;ORAL 019012-004 Feb 25, 2000 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
J And J GRIFULVIN V griseofulvin, microcrystalline TABLET;ORAL 060618-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for J And J

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
J And J Consumer Inc PEPCID AC famotidine TABLET, CHEWABLE;ORAL 020801-001 Sep 24, 1998 5,667,794*PED ➤ Try a Free Trial
J And J Consumer Inc TYLENOL acetaminophen TABLET, EXTENDED RELEASE;ORAL 019872-001 Jun 8, 1994 4,820,522 ➤ Try a Free Trial
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020902-001 Aug 5, 1999 5,667,794*PED ➤ Try a Free Trial
J And J Consumer Inc JUNIOR STRENGTH MOTRIN ibuprofen TABLET, CHEWABLE;ORAL 020601-003 Nov 15, 1996 5,215,755*PED ➤ Try a Free Trial
J And J Consumer Inc PEPCID COMPLETE calcium carbonate; famotidine; magnesium hydroxide TABLET, CHEWABLE;ORAL 020958-001 Oct 16, 2000 5,817,340*PED ➤ Try a Free Trial
J And J Consumer Inc IMODIUM loperamide hydrochloride CAPSULE;ORAL 017694-001 Approved Prior to Jan 1, 1982 3,714,159 ➤ Try a Free Trial
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020902-001 Aug 5, 1999 5,854,267*PED ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for J AND J drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Chewable Tablets 5 mg and 10 mg ➤ Subscribe 2005-03-25
➤ Subscribe Syrup 5 mg/5 mL ➤ Subscribe 2007-03-19
➤ Subscribe Chewable Tablets 800 mg/ 10 mg/ 165 mg (OTC) ➤ Subscribe 2004-11-01

International Patents for J And J Drugs

Country Document Number Estimated Expiration
South Africa 200002892 ➤ Try a Free Trial
Portugal 1404304 ➤ Try a Free Trial
South Korea 20010007332 ➤ Try a Free Trial
Colombia 5540370 ➤ Try a Free Trial
Japan 2004536829 ➤ Try a Free Trial
Austria 432068 ➤ Try a Free Trial
United Kingdom 9706842 ➤ Try a Free Trial
Country Document Number Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for J And J Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB98/013 United Kingdom ➤ Try a Free Trial PRODUCT NAME: LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE; REGISTERED: UK 00242/0314 19970923
2014 00050 Denmark ➤ Try a Free Trial PRODUCT NAME: EZETIMIBE AND ATORVASTATIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, INCLUDING ATORVASTATIN AS ATORVASTATIN CALCIUM TRIHYDRATE; REG. NO/DATE: DE/H/3895-3898/001-004/DC 20140910
00125 Netherlands ➤ Try a Free Trial PRODUCT NAME: ROSUVASTATINUM, DESGEWENST IN DE VORM VAN EEN NIET-TOXISCH FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER HET CALCIUMZOUT; REGISTRATION NO/DATE: RVG 26872 - RVG 26874 20021106
C0004 France ➤ Try a Free Trial PRODUCT NAME: DESLORATADINE; PSEUDOEPHEDRINE SULFATE; REGISTRATION NO/DATE: EU/1/07/399/001 20070730
C/GB08/018 United Kingdom ➤ Try a Free Trial PRODUCT NAME: FOSAMPRENAVIR CALCIUM: ((1S,2R)-3-(((4-AMINOPHENYL)SULFONYL)(2-METHYLPROPYL)AMINO)-1-(PHENYLMETHYL)-2(PHOSPHONOOXY)PROPYL)-CARBABAMIC ACID C-((3S)-TETRAHYDRO-3-FURANYL) ESTER CALCIUM SALT; REGISTERED: UK EU/1/04/282/001 20040712; UK EU/1/04/282/002 20040712
2008006 Lithuania ➤ Try a Free Trial PRODUCT NAME: FOSAMPRENAVIR CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001-002 20040712
2018 00006 Denmark ➤ Try a Free Trial PRODUCT NAME: PATIROMER SORBITEX CALCIUM AND ANY SALTS AND DERIVATIVES THEREOF; REG. NO/DATE: EU/1/17/1179/001-009 20170721
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Queensland Health
Citi
McKinsey
Argus Health
US Army
Chinese Patent Office
Fuji
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.